According to Pharmaion “United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the breast cancer diagnostic devices market in the United States during the period 2010 - 2020.

1. P h a r m a & H e a l t h c a r e C o n s u l t a n t s
United States Breast Cancer Diagnostic
Devices Market Opportunities, 2010 - 2020

2. 2
© Pharmaion
I n d u s t r y B r i e f
United States Breast Cancer Diagnostic Devices Market to Cross $ 2 billion by 2020
Increasing awareness about the benefits of early diagnosis and growing technological advancements to drive
United States breast cancer diagnostics devices market through 2020
According to Pharmaion report, “United States Breast Cancer Diagnostics Devices Market Opportunities,
2010 - 2020”, breast cancer diagnostic devices market in the United States is projected to cross US$ 2 billion by
2020. Growing prevalence of breast cancer, ageing demographics and rising awareness about breast cancer
and early diagnosis are projected to propel growth in the United States breast cancer diagnostic devices
through 2020. Moreover, favorable reimbursement scenario in the country is encouraging citizens to visit
diagnostic laboratories and hospitals for breast cancer screening, consequently aiding growth of the breast
cancer diagnostic devices market in the United States.
High prevalence of breast cancer and associated mortality is also motivating the government to take initiatives
to improve breast cancer survival rate. Centers for Disease Control and Prevention (CDC) initiated National
Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide timely breast and cervical cancer
screening, and breast cancer services to low income, uninsured and undeserved women in the United States.
Moreover, various breast cancer associated non-profit organizations in the United States organize “Breast
Cancer Month” each year in November to increase awareness about the disease and promote the need for
early diagnosis.
In terms of test type, the United States breast cancer diagnostic devices market has been segmented into
three categories - screening and diagnostic imaging devices, lab diagnostic devices, and others. Screening and
diagnostic imaging devices dominated the United States breast cancer diagnostic devices market in 2014 and
the segment is anticipated to continue its dominance through 2020. South region, followed by Midwest, are
the leading regional markets for breast cancer diagnostic devices in the United States. Few of the leading
companies operating in the United States breast cancer diagnostic devices market include Hologic Inc.,
Siemens Healthcare Diagnostics, Inc., Devicor Medical Products and GE Healthcare, among others.

3. 3
Ta b l e o f C o n t e n t s
© Pharmaion
S. No. Contents
1. Breast Cancer Diagnostic Devices Overview
2. United States Breast Cancer Epidemiology
3. Research Methodology
4. Analyst View
5. Global Breast Cancer Diagnostic Devices Market Overview
6. United States Breast Cancer Diagnostic Devices Market Overview
7. United States Breast Cancer Diagnostic Devices Market Outlook
7.1. Market Size and Forecast
7.1.1. By Value
7.2. Market Share and Forecast
7.2.1. By Test Type
7.2.2. By End-user
7.2.3. By Region
7.2.4. By Company
8. United States Screening and Diagnostic Imaging Devices Market Outlook
8.1. Market Size and Forecast
8.1.1. By Value
8.2. Market Share and Forecast
8.2.1. By Test Type
8.3. United States Mammography Market Outlook
8.3.1. Market Size and Forecast
8.3.1.1. By Value
8.3.2. Market Share and Forecast

4. 4
Ta b l e o f C o n t e n t s
© Pharmaion
S. No. Contents
8.3.2.1. By Type
9. United States Lab Diagnostic Devices Market Outlook
9.1. Market Size and Forecast
9.1.1. By Value
9.2. Market Share and Forecast
9.2.1. By Test Type
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Contrast-enhanced Mammography
11.2. Novel Breast Cancer Diagnostics Biomarkers
11.3. Vacuum-Assisted Biopsy
11.4. CAD for Mammography
11.5. Scintimammography
12. United States Economic Profile
13. Regulatory Landscape
14. Reimbursement Scenario for Breast Cancer Diagnostic Procedures
15. Competitive Landscape
15.1. Competitive Benchmarking
15.2. Company Profiles
15.2.1. Hologic Inc.
15.2.2. Siemens Healthcare Diagnostics, Inc

5. 5
Ta b l e o f C o n t e n t s
© Pharmaion
S. No. Contents
15.2.3. Devicor Medical Products, Inc. (Mammotome)
15.2.4. GE Healthcare
15.2.5. Philips Healthcare
15.2.6. Carestream Health
15.2.7. Fujifilm Medical Systems, U.S.A., Inc.
15.2.8. IMS S.r.l.
15.2.9. Planmed OY
15.2.10. CareFusion Corporation
16. Strategic Recommendations
17. About US & Disclaimer

6. 6
R e s e a r c h M e t h o d o l o g y
Primary Research
•Identifying Key Opinion Leaders
•Questionnaire Design
•In-depth Interviews
•Coverage across Value Chain
market
Market Estimation & Forecasting
Bottom-Up or Top-down approach for Market size estimation
Historical trend examination
Impact analysis of drivers and challenges to market growth
Statistical evaluation to develop the actual forecast
Data Validation, Analysis and Interpretation
Data validation through Primary & Secondary outreach, data analysis and
interpretation of key findings
Preliminary Data Mining
Qualitative and Quantitative research
2015E 2016F 2017F 2018F 2019F 2020F
CAGR (2015E-2020F): XX%
US Breast Cancer Diagnostic Devices
Market Opportunities, 2010-2020
Secondary Research
•Government websites
•Company annual reports
•White papers
•Investor presentation
•Financial reports
© Pharmaion

7. 7
Baseline Methodology:
For the study of the United States breast cancer diagnostic devices market, Pharmaion has gathered
information through an exhaustive search of credible databases prudently evaluated all the collected
information and presented it in the most accurate and detailed manner.
Primary Sources
Key Stakeholders:
 Product/Brand Managers
 Business Development
Managers
 Regional Mangers
 Regulatory Affairs Personnel
 Marketing & Sales Managers
 Head of Patient Support
Programme
Substantial data points for analysis,
interpretation and market size estimation
Data
Triangulation
(Data
validation
through cross
verification
from primary
& secondary
sources)
Qualitative and
quantitative data
from company
website, financial
reports, research
articles, designed
questionnaires
etc.
In-depth
interviews of key
stakeholders of
major companies
Secondary Sources
Analysis of Data from credible
sources:
 Centers for Disease Control
and Prevention (CDC)
 American Cancer Institute
 American College of
Radiology
© Pharmaion
R e s e a r c h M e t h o d o l o g y

8. 8
Calculation of United
States Breast Cancer
Screening and Diagnostic
Imaging Devices, Lab
Diagnostic Devices and
Others Market Size
Separately
United States Breast Cancer Diagnostic Devices Market - Market Size Estimation
 United States breast cancer diagnostic devices market has been segmented into three categories,
namely, Screening and Diagnostic Imaging Devices, Lab Diagnostic Devices and Others.
 Screening and Diagnostic Imaging Devices segment has been further categorized into three sub-
segments, i.e., Mammography, Breast Ultrasound and Breast MRI.
 Lab Diagnostic Devices segment has been further classified into two sub-segments, namely, Breast
Biopsy Devices and Lab Tests.
Calculation of United
States Breast Cancer
Screening and Diagnostic
Imaging Devices, Lab
Diagnostic Devices and
Others Market Size
Separately
Top-downApproach
Bottom-upApproach
Calculation
of Sub-
segment
market size
Total Market
Size =
Screening and
Diagnostic
Imaging
Devices + Lab
Diagnostic
Devices +
Others
Market Size
(By Region and
Company)
=
Respective Market
Share (From
Primary And
Secondary
Research)
X
Total Segment
Market Size
© Pharmaion
R e s e a r c h M e t h o d o l o g y

9. 9
S a m p l e D a t a - S n a p s h o t
10 20 30 40 50 60 70 80 90 100 110
2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F
United States Breast Cancer Diagnostic Devices
Market Size, By Value, 2010-2020F (USD Billion)
© Pharmaion
United States Breast Cancer Diagnostic Devices
Market Share, By Test Type, By Value, 2010-2020F
5.0% 5.1% 5.2% 5.3% 5.4% 5.5% 5.6% 5.7% 5.8% 5.9% 6.0%
47% 47% 47% 47% 47% 47% 47% 47% 46% 46% 46%
45% 46% 47% 48% 49% 50% 51% 52% 53% 54% 55%
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
Screening and Diagnostic Imaging Devices
Lab Diagnostic Devices
Others
10
20
30
40
50
2010 2011 2012 2013 2014
North-East Region
10 20 30 40 50
2010 2011 2012 2013 2014
West Region
10 20 30 40 50
2010 2011 2012 2013 2014
Midwest Region
10 20 30 40 50
2010 2011 2012 2013 2014
South Region
United States Breast Cancer Diagnostic Devices Market
Size, By Region, By Value, 2010-2014 (USD Million) Segmental Revenue Break Up, FY 2015
Diagnostics, 25%
Breast Health,
25%
GYN surgical, 25%
Skeletal…
United
States,…
Europe,…
Asia-
Pacific,
25%
Other international
markets, 25%
Hologic, Inc. (NASDAQ: HOLX)
By Business
Segments
By Geography
Debt and Cash Availability (USD
Million)
10
20
5 10
FY 2015 FY 2014
Debt Cash and Cash Equivalent
United States Lab Diagnostic Devices Market
Share, By Test Type, By Value, 2010-2020F
24% 25% 26% 27% 28% 29% 30% 31% 32% 33% 34%
76% 75% 74% 73% 72% 71% 70% 69% 68% 67% 66%
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
Breast Biopsy Lab Tests
Institution
al, 50%
Non-
institutional,
50%
Ownership
Structure, 2014

10. R e p o r t O r d e r i n g
To View Sample OR Purchase Report
Report Price
Report Name: United States Breast Cancer Diagnostic Devices
Market Opportunities, 2010 - 2020
License Type Price
Single User License $2500
Single User License Print $3000
Enterprise License $5000
10

11. 11
A b o u t U s & D i s c l a i m e r
NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
sales@pharmaion.com
+1 646 862 0089
www.pharmaion.com
About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its
customers with high value market research and advisory services that helps them identify new market opportunities, growth
engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market
trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an
increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional
market research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable and
interactive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with
comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-
trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research
and consulting requirements.
Related Reports
India Stem Cell Market Forecast & Opportunities, 2010-2020
India Infertility Treatment Market Forecast & Opportunities, 2010-2020
Global Tissue Engineered Medical Device Market Forecast & Opportunities, 2010-2020
Disclaimer :
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is
made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been
obtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the
accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the
use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The
information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative
of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of Pharmaion Consultants.
ASIA PACIFIC
Pharmaion Consultants Pvt. Ltd.
A – 51, Sector 57, Noida, National Capital Region,
India - 201301
sales@pharmaion.com
+91 - 120 - 452 3900
www.pharmaion.com © Pharmaion